Safety of Interferon Products: a Retrospective Analysis of Adverse Reactions Spontaneously Reported in the Republic of Crimea
Journal: Health Food & Biotechnology
Year: 2021

The modern pharmaceutical market is represented by a large number of natural and synthetic (recombinant) interferon drugs, available in different dosage forms for both local and systemic action, but the data on the safety of this group of drugs is rather limited. This requires additional study of the features and severity of adverse reactions (AR) associated with the use of this pharmaceutical group in the treatment of various nosologies. The aim of the study was to study the main manifestations